Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-047423

President & CEO acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-08-23 Option exercise +30,000 $16.31 $489,300 312,775 D
Derivatives
ROBIN HOWARD W President & CEO 2019-08-23 Option exercise · Common Stock −30,000 195,000 D
Loading xslF345X03/doc4.xml…